Navigation Links
CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
Date:9/4/2007

LAGUNA HILLS, Calif., Sept. 4 /PRNewswire/ -- CODA Genomics, Inc., a pioneer in applying its namesake technology, (Computational Optimized DNA Assembly) towards the manufacture of synthetic genes and other DNA fragments, announced today that the US Patent and Trademark Office has issued US Patent 7,262,031 to its two founding scientists, University of California, Irvine (UCI) professors, Richard H. Lathrop and G. Wesley Hatfield. The technology was developed under a prestigious Information Technology Research grant from the National Science Foundation jointly in the School of Medicine and the Donald Bren School of Information and Computer Sciences at UCI. The Company has licensed this patent exclusively from the UCI's Office of Technology Assessment (OTA).

US Patent 7,262,031 entitled, "Method for Producing a Synthetic Gene or Other DNA Sequence," teaches how to use a global (across all possible correct and incorrect gene assemblies) optimization method for the choice of DNA code to make a given protein. Properly chosen DNA enables the thermodynamically controlled self-assembly of only the desired DNA product(s). The synthetic gene is simultaneously optimized for many other parameters that affect the successful use of the gene to make protein efficiently in any desired biological system.

Dr. Robert J Molinari, Ph.D., CODA's CEO said, "This broad protection of CODA's breakthrough technology will allow the company to aggressively market its high-yielding Hot-RodTM genes, and other optimized gene variant sets. For the customer, it allows a scaleable way to test a large number of gene and protein variants for desirable properties."

David Schetter, assistant Vice-chancellor, Research and Technology Alliances, at UCI adds "CODA has been one of UCI's first, successful examples of OTA's "Virtual Incubation" model where early stage technology is licensed to a start-up company and the technology is incubated in the University by way of a series of standard agreements for research, technology development and access to UCI's facilities and equipment. All of these agreements are negotiated at arm's length and meet the university's standards for proper use of university facilities and mitigation of conflicts of interest. As a result, the University gains additional resources and a role in ensuring the success of the technology while the company does not incur premature and expensive spin-out costs. Additionally, with more well developed and proven technology, the company is better able to raise required capital to move to its non-virtual stage."

About CODA Genomics, Inc.

CODA Genomics, Inc. is a protein Translation Engineering company focused on proprietary patented approaches to express proteins in a variety of organisms. This unique technology enables synthetic biology to solve many protein expression problems. For more CODA information, visit http://www.codagenomics.com.


'/>"/>
SOURCE CODA Genomics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Genomics researcher Hood joins NimbleGen board
3. GE Healthcare partners with genomics institute
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Total Orthopedics ... implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place on Wednesday, January 11, 2017 ... procedure was an anterior cervical discectomy and fusion on a 42 year old ...
(Date:1/18/2017)... ... ... from a new study are stating that if levels of the blood test called ... there is still remaining prostate cancer cells that are more likely to come back, spreading ... an indicator of whether a man’s prostate cancer is growing or not,” stated Dr. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Thirty-six startup companies in ... by the Pennsylvania Department of Community and Economic Development in 2016 as part of ... in the University City Keystone Innovation Zone and represent the highest number of awards ...
(Date:1/18/2017)... 18, 2017 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... company that develops and commercializes proprietary technologies and ... "Company"), today announced that Cameron Prange , ... resigned from its Board of Directors.  Mr. Prange,s ... regulations that have limited both his ability to ...
Breaking Biology Technology:
(Date:12/16/2016)... global wearable medical device market, in terms of value, is projected ... in 2016, at a CAGR of 18.0% during the forecast period. ... Growth in ... launch of a growing number of smartphone-based healthcare apps compatible with ... increasing focus on physical fitness. Furthermore, growing trend ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection ... Voice Recognition), Service, Application Area, End User, And Region - Global Forecast to ... 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a Compound ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):